What Happened?. Shares of global pharmaceutical company Eli Lilly (NYSE. LLY) jumped 3% in the afternoon session after the stock benefited as investors rotated capital out of the volatile technology sector and into defensive names ... More News. ViewMore ... .
What Happened?. Shares of global pharmaceutical company Eli Lilly (NYSE. LLY) jumped 3.4% in the morning session after the company announced highly positive Phase 3 trial results for its next-generation weight loss candidate, retatrutide ... More News ... .
LLY) to push higher from current levels – at least in the near-term. LLY shares have been standout performers in 2025 – riding the wave of investor enthusiasm around its obesity and diabetes drugs (Zepbound and Mounjaro).
LLY) has officially joined the trillion-dollar market cap club, cementing its place among the world’s most valuable companies ... LLY stock has gained over 70% in less than four months, pushing past the symbolic trillion-dollar threshold.
What Happened?. Shares of global pharmaceutical company Eli Lilly (NYSE. LLY) jumped 3.1% in the morning session after the company reported a "beat and raise" quarter ... After the initial pop the shares cooled down to $847.92, up 4.2% from previous close.
LLY) reported revenue ahead of WallStreets expectations in Q3 CY2025, with sales up 53.9% year on year to $17.6 billion ...Eli Lilly (LLY) Q3 CY2025 Highlights. ... LLY) discovers, develops, and ...
Global pharmaceutical company Eli Lilly (NYSE. LLY) will be announcing earnings results this Thursday before market open. Here’s what investors should know ... Adjusted earnings are expected to come in at $5.92 per share ... More News. ViewMore ... Via MarketBeat.
U.S. pharmaceutical stocks have done well of late, as large drugmakers such as Pfizer and AstraZeneca signed drug pricing agreements with the Trump Administration... .
What Happened? ...LLY) fell 3.5% in the afternoon session after political comments introduced significant uncertainty regarding the future pricing of the company’s weight-loss and diabetes drugs, Zepbound and Mounjaro ... drug prices ... More News. ViewMore ... .